A bill to allow women greater access to safe and effective contraception.

Introduced in Senate
Allowing Greater Access to Safe and Effective Contraception Act

This bill requires the Food and Drug Administration (FDA) to prioritize review
of supplemental drug applications (applications to modify the approved use of a
drug) for contraceptive drugs intended for routine use that would be available
to individuals aged 18 and older without a prescription. The FDA must waive user
fees for such supplemental drug applications. Any drug that is eligible for this
priority review must be a prescription drug for individuals under age 18.

This bill repeals provisions of the Patient Protection and Affordable Care Act
and the Health Care and Education Reconciliation Act of 2010 to allow health
savings accounts and health flexible spending accounts (HFSAs) to be used to pay
for medicine without a prescription and to remove the limit on salary reduction
contributions to a HFSA under a cafeteria plan, effective as if the provisions
had never been enacted.



  • Read twice and referred to the Committee on Finance.

    Jan 10th, 2017
  • Introduced in Senate

    Jan 10th, 2017